Sufentanil citrate and Bronchospasm - a phase IV clinical study of FDA data

Summary:

Bronchospasm is reported as a side effect among people who take Sufentanil citrate (sufentanil citrate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Diprivan, and have Anaesthesia.

The phase IV clinical study analyzes which people have Bronchospasm when taking Sufentanil citrate. It is created by eHealthMe based on reports of 1,790 people who have side effects when taking Sufentanil citrate from the FDA, and is updated regularly.

What is Sufentanil citrate?

Sufentanil citrate has active ingredients of sufentanil citrate. eHealthMe is studying from 1,794 Sufentanil citrate users. Check the latest studies of Sufentanil citrate.

What is Bronchospasm?

Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi) is found to be associated with 1,119 drugs and 1,099 conditions by eHealthMe. Check the latest studies of Bronchospasm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

1,790 people reported to have side effects when taking Sufentanil citrate.
Among them, 93 people (5.2%) have Bronchospasm.

Could Sufentanil citrate cause Bronchospasm?

Among these 93 people:

How long have people been on Sufentanil citrate when they have Bronchospasm? *

What is the gender of people who have Bronchospasm when taking Sufentanil citrate? *

female: 57.3 %
male: 42.7 %

What is the age of people who have Bronchospasm when taking Sufentanil citrate? *

What are other drugs people take besides Sufentanil citrate? *

What are other side effects people have besides Bronchospasm? *

Hypotension (abnormally low blood pressure): 38 people, 40.86%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 36 people, 38.71%
Oxygen Saturation Decreased: 16 people, 17.20%
Rashes (redness): 15 people, 16.13%
Circulatory Collapse: 12 people, 12.90%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 12 people, 12.90%
Arrhythmias (irregular heartbeat): 9 people, 9.68%
Generalised Erythema (redness of the skin all over the body): 6 people, 6.45%
Urticaria (rash of round, red welts on the skin that itch intensely): 6 people, 6.45%
Cardiac Arrest: 6 people, 6.45%

What are the existing conditions these people have? *

Anaesthesia: 20 people, 21.51%
General Anaesthesia: 14 people, 15.05%
Neuromuscular Blockade: 2 people, 2.15%
Local Anaesthesia: 2 people, 2.15%
Gait Disturbance: 2 people, 2.15%
Asthma: 2 people, 2.15%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.08%
High Blood Pressure: 1 person, 1.08%
High Blood Cholesterol: 1 person, 1.08%
Depression: 1 person, 1.08%

* Approximation only. Some reports may have incomplete information.

Do you take Sufentanil citrate and have Bronchospasm?

- Check whether Bronchospasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sufentanil citrate:

Sufentanil citrate (1,794 reports)

Bronchospasm treatments and more:

Bronchospasm (18,622 reports)

Browse all side effects of Sufentanil citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchospasm:

Bronchospasm (1,119 drugs)

Browse all the conditions that are associated with Bronchospasm:

Bronchospasm (1,099 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sufentanil citrate (the active ingredients of Sufentanil citrate) and Sufentanil citrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.